Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults

Publication date: Available online 28 October 2023Source: Journal of InfectionAuthor(s): Zhili Jin, Jingxuan Wu, Ying Wang, Tao Huang, Kexin Zhao, Jian Liu, Haomeng Wang, Tao Zhu, Jinbo Gou, Haitao Huang, Xiaofang Wu, Hang Yin, Jian Song, Ran Li, Jianx…